TIMP2 and neoplasm: There were no statistically significant differences for TIMP-2 EV-mRNA levels between patients with localized versus metastatic disease (p = 0.338) nor in terms of tumor size in the patients presenting localized disease (p = 0.477) (Figure 4D,E).